Outcome/subgroup
|
Women
|
Men
|
OR/B of women (95% CI)
|
P for interaction
|
---|
In-hospital mortality
| | | |
0.188
|
PCI
|
1277 (9.8%)
|
1184 (9.1%)
|
1.09 (1.001–1.19)
| |
CABG
|
360 (21.0%)
|
371 (21.6%)
|
0.96 (0.82–1.14)
| |
IABP support
| | | |
0.070
|
PCI
|
1435 (11.0%)
|
1691 (12.9%)
|
0.83 (0.77–0.90)
| |
CABG
|
660 (38.5%)
|
677 (39.5%)
|
0.96 (0.84–1.10)
| |
ECMO support
| | | |
0.236
|
PCI
|
95 (0.7%)
|
147 (1.1%)
|
0.64 (0.49–0.83)
| |
CABG
|
105 (6.1%)
|
129 (7.5%)
|
0.80 (0.62–1.05)
| |
New onset ischemic stroke
| | | |
0.758
|
PCI
|
235 (1.8%)
|
197 (1.5%)
|
1.20 (0.99–1.45)
| |
CABG
|
72 (4.2%)
|
57 (3.3%)
|
1.28 (0.90–1.82)
| |
Pneumonia
| | | |
0.694
|
PCI
|
995 (7.6%)
|
1118 (8.6%)
|
0.88 (0.81–0.96)
| |
CABG
|
162 (9.4%)
|
190 (11.1%)
|
0.84 (0.67–1.05)
| |
GI bleeding
| | | |
0.825
|
PCI
|
799 (6.1%)
|
796 (6.1%)
|
1.00 (0.91–1.11)
| |
CABG
|
74 (4.3%)
|
71 (4.1%)
|
1.04 (0.75–1.46)
| |
New onset dialysis
| | | |
0.223
|
PCI
|
784 (6.0%)
|
740 (5.7%)
|
1.07 (0.96–1.18)
| |
CABG
|
301 (17.5%)
|
317 (18.5%)
|
0.94 (0.79–1.12)
| |
Prolonged ventilationa
| | | |
0.880
|
PCI
|
1265 (9.7%)
|
1242 (9.5%)
|
1.02 (0.94–1.11)
| |
CABG
|
587 (34.2%)
|
574 (33.4%)
|
1.03 (0.90–1.19)
| |
Hospital stays (days)
| | | |
< 0.001
|
PCI
|
10.6 ± 12.1
|
10.0 ± 11.8
|
0.69 (0.40, 0.98)
| |
CABG
|
28.3 ± 20.1
|
25.8 ± 18.8
|
2.5 (1.2, 3.8)
| |
ICU duration (days)
| | | |
0.007
|
PCI
|
4.9 ± 6.5
|
4.8 ± 6.4
|
0.17 (0.02, 0.33)
| |
CABG
|
13.0 ± 11.1
|
12.1 ± 10.8
|
0.87 (0.14, 1.60)
| |
Medical expenditure (USD × 103)
| | | |
0.001
|
PCI
|
7.8 ± 5.6
|
7.8 ± 5.7
|
0.04 (− 0.10, 0.17)
| |
CABG
|
20.1 ± 9.9
|
19.3 ± 9.7
|
0.78 (0.12, 1.44)
| |
- Data were given as frequency (percentage%) or mean ± standard deviation
- IABP intra-aortic balloon pumping, ECMO extra-corporeal membrane oxygenation, USD US dollars, OR odds ratio, B regression coefficient, CI confidence interval, ICU intensive care unit, USD US dollar
- aThe dependence on mechanical ventilation for seven days or longer